EFM
DYN icon

E Fund Management’s Dyne Therapeutics DYN Stock Holding History

E Fund Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Buy
+23,001
New +$397K 0.01% 325
2025
Q2 		$117K Sell
12,274
-1,497
-11% -$16.5K 0.01% 373
2025
Q1 		$144K Buy
13,771
+1,923
+16% +$27.5K 0.01% 373
2024
Q4 		$279K Buy
11,848
+1,249
+12% +$36.9K 0.01% 326
2024
Q3 		$381K Buy
10,599
+1,770
+20% +$70.4K 0.02% 228
2024
Q2 		$312K Sell
8,829
-7,446
-46% -$216K 0.02% 226
2024
Q1 		$462K Buy
+16,275
New +$368K 0.03% 168

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

E Fund Management's DYN Position: Q1 2026 in Review

E Fund Management opened a new position in Dyne Therapeutics (DYN) in Q1 2026: 23,001 shares worth $417K. The stake represents 0.01% of the portfolio and ranks #325 among its holdings. This is a return to the name: E Fund Management previously reported a position in DYN as recently as Q2 2025.

E Fund Management first reported a position in DYN in Q1 2024 and has held it in 7 quarters since. The position peaked at $462K in Q1 2024. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • E Fund Management held 23,001 shares of Dyne Therapeutics worth $417K as of Q1 2026.
  • Dyne Therapeutics was a new E Fund Management position in Q1 2026.
  • Dyne Therapeutics made up 0.01% of E Fund Management's portfolio in Q1 2026, its #325 holding.
  • E Fund Management first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • E Fund Management's Dyne Therapeutics position peaked at $462K in Q1 2024.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.